These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33567468)

  • 1. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
    Abdelmeguid AS; Teeramatwanich W; Roberts DB; Amit M; Ferraroto R; Glisson BS; Kupferman ME; Su SY; Phan J; Garden AS; Raza SM; DeMonte F; Hanna EY
    Cancer; 2021 Jun; 127(11):1788-1795. PubMed ID: 33567468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses.
    Hanna EY; Cardenas AD; DeMonte F; Roberts D; Kupferman M; Weber R; Rosenthal D; Kies M
    Arch Otolaryngol Head Neck Surg; 2011 Jan; 137(1):78-81. PubMed ID: 21242552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
    Ock CY; Keam B; Kim TM; Han DH; Won TB; Lee SH; Hah JH; Kwon TK; Kim DW; Kim DY; Rhee CS; Wu HG; Sung MW; Heo DS
    Korean J Intern Med; 2016 May; 31(3):570-8. PubMed ID: 26976150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of induction chemotherapy for oral cavity squamous cell carcinoma.
    Abdelmeguid AS; Silver NL; Boonsripitayanon M; Glisson BS; Ferrarotto R; Gunn GB; Phan J; Gillenwater AM; Hanna EY
    Cancer; 2021 Sep; 127(17):3107-3112. PubMed ID: 33909292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for organ preservation in sinonasal squamous cell carcinoma.
    Wang T; Li Y; Wang L; Wang J; Zhao K; Song X
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):775-784. PubMed ID: 37707615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results.
    Lee MM; Vokes EE; Rosen A; Witt ME; Weichselbaum RR; Haraf DJ
    Cancer J Sci Am; 1999; 5(4):219-23. PubMed ID: 10439167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results.
    Hanna E; DeMonte F; Ibrahim S; Roberts D; Levine N; Kupferman M
    Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1219-24. PubMed ID: 20026819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical study of multimodal treatment for orbital organ preservation in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus.
    Chen NX; Chen L; Wang JL; Wang JY; Yan F; Ma L; Zhang XX
    Jpn J Clin Oncol; 2016 Aug; 46(8):727-34. PubMed ID: 27207888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care Therapy.
    Murr AT; Lenze NR; Weiss JM; Grilley-Olson JE; Patel SA; Shen C; Chera BS; Zanation AM; Thorp BD; Sheth SH
    Otolaryngol Head Neck Surg; 2022 Nov; 167(5):846-851. PubMed ID: 35259033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Induction Therapy for Sinonasal Cancers.
    Kong KA; Thorp BD; Sheth SH
    Curr Treat Options Oncol; 2023 Mar; 24(3):162-169. PubMed ID: 36696082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
    Guan X; Wang X; Liu Y; Hu C; Zhu G
    Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis.
    Khademi B; Moradi A; Hoseini S; Mohammadianpanah M
    Oral Maxillofac Surg; 2009 Dec; 13(4):191-9. PubMed ID: 19795137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definitive and adjuvant radiotherapy for sinonasal squamous cell carcinomas: a single institutional experience.
    Duru Birgi S; Teo M; Dyker KE; Sen M; Prestwich RJ
    Radiat Oncol; 2015 Sep; 10():190. PubMed ID: 26377408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal Cavity Squamous Cell Carcinoma: Factors Associated With Treatment Outcomes and Potential Organ Preservation.
    Issa K; Teitelbaum J; Smith BD; Wang F; Ackall F; Sargi Z; Rangarajan SV; Jung SH; Jang DW; Abi Hachem R
    Am J Rhinol Allergy; 2023 Jan; 37(1):35-42. PubMed ID: 36189818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Standards for Organ Preservation in Locoregionally Advanced Non-nasopharyngeal Head and Neck Cancer and Evolving Strategies for Favorable-Risk and Platinum-Ineligible Populations.
    Wu SY; Yom SS
    Curr Treat Options Oncol; 2019 Dec; 20(12):89. PubMed ID: 31797157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyriform sinus squamous cell carcinoma: oncological outcomes in good responders of induction chemotherapy-based larynx preservation protocols.
    Vourexakis Z; Le Ridant AM; Dulguerov P; Janot F
    Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1725-31. PubMed ID: 24854231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of preoperative radiotherapy in the treatment of locally advanced nasal cavity and paranasal sinus squamous cell carcinoma: A single institutional experience.
    Wang Z; Qu Y; Wang K; Wu R; Zhang Y; Huang X; Zhang S; Xiao J; Yi J; Gao L; Xu G; Luo J
    Oral Oncol; 2020 Feb; 101():104512. PubMed ID: 31869689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Kong L; Zhang Y; Hu C; Guo Y; Lu JJ
    Cancer; 2017 Jun; 123(12):2258-2267. PubMed ID: 28192641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
    Seiwert TY; Melotek JM; Blair EA; Stenson KM; Salama JK; Witt ME; Brisson RJ; Chawla A; Dekker A; Lingen MW; Kocherginsky M; Villaflor VM; Cohen EE; Haraf DJ; Vokes EE
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):21-9. PubMed ID: 27511844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.